1. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England
- Author
-
Victoria Hall, Gwenda Hughes, Nigel Field, John Saunders, Martina Furegato, Holly Mitchell, Koh Jun Ong, Hamish Mohammed, Monica Desai, Sarika Desai, and O Noel Gill
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Population ,Human immunodeficiency virus (HIV) ,HIV Infections ,Dermatology ,medicine.disease_cause ,Proxy (climate) ,Men who have sex with men ,Young Adult ,Pre-exposure prophylaxis ,Disease Transmission, Infectious ,Humans ,Medicine ,Homosexuality, Male ,education ,Reproductive health ,Population Density ,education.field_of_study ,business.industry ,Incidence ,Public health ,Hiv incidence ,virus diseases ,Middle Aged ,Infectious Diseases ,England ,Pre-Exposure Prophylaxis ,business ,Demography - Abstract
ObjectivesThe size of the population of men who have sex with men (MSM) who may be eligible for HIV pre-exposure prophylaxis (HIV-PrEP) in England remains unknown. To plan for a national PrEP implementation trial, we estimated the number of MSM attending sexual health clinics (SHCs) that may be eligible for HIV-PrEP in England.MethodsSexually transmitted infection (STI) surveillance data from 2010 to 2015 from the GUMCAD surveillance system were used to estimate the annual number of HIV-negative MSM who may be eligible for HIV-PrEP in England. Based on national eligibility criteria, we identified HIV-negative MSM attending SHCs with a HIV-negative test in the past year and used diagnosed bacterial STI (past year) in this group as a proxy for condomless sex and eligibility for HIV-PrEP. We estimated HIV incidence per 100 person-years (py) in these groups in 2014.ResultsDuring 2010–2015, the number of HIV-negative MSM attending SHCs with a HIV-negative test in the past year doubled from 14 643 to 29 023, and HIV incidence in this group was 1.9 (95% CI 1.6 to 2.2) per 100 py in 2014. In the same period, the subgroup with a bacterial STI diagnosis (past year), and therefore considered potentially eligible for HIV-PrEP in this analysis, increased from 4365 (30%) to 10 276 (35%). HIV incidence in this subgroup was 3.3 (95% CI 2.7 to 4.0) per 100 py in 2014.ConclusionsIn 2015, approximately 10 000 HIV-negative MSM were considered potentially eligible for HIV-PrEP based on clinic history in GUMCAD. These data were used to inform the initial recruitment target for the PrEP Impact Trial and will inform future evaluations at a population level.
- Published
- 2019